Ultra-Small Cu-Au Bimetallic Nanozyme with Infinitesimal Steric Hindrance to Promote the Rapid Lateral Flow Detection of Clenbuterol
Huilan Hu,Di Yang,Lei Zhao,Shaochi Wang,Jing Ren,Xuechi Yin,Yanli Tian,Conghui Jia,Jianlong Wang,Daohong Zhang
DOI: https://doi.org/10.2139/ssrn.4410655
2022-01-01
SSRN Electronic Journal
Abstract:Lateral flow immunoassay (LFIA) has received widespread attention in veterinary drug residues detection. Nanozyme, an excellent signal label, has been widely used in the detection of veterinary drug residues. Herein, a highly sensitive LFIA is developed for the enzyme-catalyzed and double-reading determination of clenbuterol (CLE), in which a new type of probe was adopted through the directly electrostatic adsorption of ultra-small copper-gold bimetallic nanoparticles (USCGs) and monoclonal antibody (mAb). In the assay, based on the peroxidase activity of USCG, the chromogenic substrate TMB-H2O2 was introduced to trigger its color development, and the results were compared with those before catalysis. Under optimal conditions, the detection sensitivity after catalysis is 0.1 ng mL-1, which is 2-fold higher than that before catalysis, and 6-fold improved than the conventional Au NPs based LFIA. The large-span detection range is achieved after catalysis, expanded from 0.2–4 ng mL-1 to 0.1–8 ng mL-1. Ultimately, the proposed USCG-based LFIA was successfully applied to the detection of CLE in food samples, with recoverable rates of 98.53%–117.79%. This work can be a promising show for the application of ultra-small bimetallic nanozyme in LFIAs.